We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$170M
AUM Growth
+$1.92M
Cap. Flow
+$1.49M
Cap. Flow %
0.88%
Top 10 Hldgs %
41.96%
Holding
117
New
6
Increased
39
Reduced
48
Closed
7

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$765K
2
AMD icon
Advanced Micro Devices
AMD
+$615K
3
GEV icon
GE Vernova
GEV
+$615K
4
DIS icon
Walt Disney
DIS
+$589K
5
ABBV icon
AbbVie
ABBV
+$504K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$506K
2
TSM icon
TSMC
TSM
+$339K
3
ALB icon
Albemarle
ALB
+$337K
4
JPM icon
JPMorgan Chase
JPM
+$310K
5
NVO
Novo Nordisk
NVO
+$298K

Sector Composition

Rank Sector Weight
1 Technology 38.64%
2 Consumer Staples 11.55%
3 Healthcare 11.29%
4 Consumer Discretionary 9.05%
5 Financials 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BX icon
76
Blackstone
BX
$102B
$387K 0.23%
2,247
-315
-12% -$54.9K
UBER icon
77
Uber
UBER
$143B
$384K 0.23%
6,365
+1,333
+26% +$95.2K
USB icon
78
US Bancorp
USB
$98.2B
$379K 0.22%
7,916
-400
-5% -$19.7K
DUK icon
79
Duke Energy
DUK
$97.8B
$370K 0.22%
3,434
– –
VFH icon
80
Vanguard Financials ETF
VFH
$13.5B
$365K 0.21%
3,092
– –
BRK.B icon
81
Berkshire Hathaway Class B
BRK.B
$1.1T
$359K 0.21%
793
-61
-7% -$28.2K
VO icon
82
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$348K 0.2%
5,272
– –
NEOG icon
83
Neogen
NEOG
$2.63B
$343K 0.2%
28,277
-14,122
-33% -$198K
PG icon
84
Procter & Gamble
PG
$336B
$332K 0.2%
1,982
– –
MCD icon
85
McDonald's
MCD
$192B
$329K 0.19%
1,136
-1
-0.1% -$298
VRTX icon
86
Vertex Pharmaceuticals
VRTX
$121B
$314K 0.18%
779
-622
-44% -$288K
SHY icon
87
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$312K 0.18%
3,800
– –
BAC icon
88
Bank of America
BAC
$435B
$303K 0.18%
6,885
-100
-1% -$4.4K
FISV
89
Fiserv Inc
FISV
$28.8B
$298K 0.18%
1,450
+320
+28% +$65.3K
SBR
90
Sabine Royalty Trust
SBR
$1.06B
$285K 0.17%
4,403
-900
-17% -$56.5K
CSCO icon
91
Cisco
CSCO
$457B
$281K 0.17%
4,750
– –
COST icon
92
Costco
COST
$422B
$272K 0.16%
297
– –
MO icon
93
Altria Group
MO
$114B
$272K 0.16%
5,206
-233
-4% -$12.4K
XYZ
94
Block Inc
XYZ
$48.4B
$249K 0.15%
2,935
-55
-2% -$4.51K
FIS icon
95
Fidelity National Information Services
FIS
$23.1B
$244K 0.14%
3,023
– –
RTX icon
96
RTX Corp
RTX
$290B
$241K 0.14%
2,084
– –
EMR icon
97
Emerson Electric
EMR
$83.9B
$238K 0.14%
+1,922
New +$233K
CB icon
98
Chubb
CB
$135B
$238K 0.14%
860
– –
QQQ icon
99
Invesco QQQ Trust
QQQ
$453B
$221K 0.13%
433
+1
+0.2% +$506
AMT icon
100
American Tower
AMT
$80.8B
$219K 0.13%
1,194
– –
1 2 3
4
5

Similar funds

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Fairfield, Bush & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fairfield, Bush & Co held 117 positions worth $170M, up 1.1% from $168M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fairfield, Bush & Co's Q4 2024 filing shows 6 new, 39 increased, 48 reduced and 7 closed positions. Its largest new stake was GE Vernova: 1,968 shares worth $647K. The largest sale was Thermo Fisher Scientific, an estimated $506K.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Fairfield, Bush & Co's largest Q4 2024 buy was GE Vernova: 1,968 shares worth $647K.
  • Fairfield, Bush & Co added most to GE Aerospace in Q4 2024, an estimated $765K increase.
  • Fairfield, Bush & Co's biggest Q4 2024 reduction was Thermo Fisher Scientific, cutting an estimated $506K.
  • Fairfield, Bush & Co fully exited Albemarle in Q4 2024, selling an estimated $337K.
  • Fairfield, Bush & Co's ten largest holdings make up 42% of its $170M portfolio in Q4 2024.
  • Fairfield, Bush & Co opened 6 new positions and closed 7 in Q4 2024.
  • Fairfield, Bush & Co's portfolio value rose 1.1% quarter-over-quarter to $170M.

Based on Fairfield, Bush & Co's 13F filing for Q4 2024, filed 13 Feb 2025.